Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Income Statement Evolution (Annual data)
Fiscal Period: February | 2022 | 2023 |
---|---|---|
Net sales | - | 0.9996 |
EBITDA | - | -0.1774 |
EBIT 1 | -0.00061 | -0.231 |
Operating Margin | - | -23.11% |
Earnings before Tax (EBT) 1 | -0.00061 | -0.3915 |
Net income 1 | -0.00061 | -0.3527 |
Net margin | - | -35.29% |
EPS | - | -0.0300 |
Free Cash Flow | - | -0.3269 |
FCF margin | - | -32.71% |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 6/2/22 | 5/30/23 |
Balance Sheet Analysis
Fiscal Period: February | 2022 | 2023 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 0.01 | 0.96 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | -0.33 |
ROE (net income / shareholders' equity) | - | -33.8% |
ROA (Net income/ Total Assets) | - | -4.97% |
Assets 1 | - | 7.102 |
Book Value Per Share 2 | 0 | 0.2200 |
Cash Flow per Share 2 | 0 | 0.2400 |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 6/2/22 | 5/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 58.67M | |
+10.11% | 127B | |
-5.15% | 11.34B | |
+6.07% | 9.11B | |
+37.46% | 5.53B | |
+8.53% | 3.45B | |
-8.69% | 2.87B | |
-6.38% | 2.1B | |
-10.91% | 2.08B | |
-23.21% | 1.78B |
- Stock Market
- Equities
- MDNC Stock
- Financials Medinotec Inc.